Unicycive Therapeutics Inc. (UNCY) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Unicycive Therapeutics In...

    NASDAQ: UNCY · Real-Time Price · USD
    4.62
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:59 PM
    4.65
    0.65%
    Pre-market: Oct 06, 2025, 04:10 AM EDT

    Unicycive Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.45 -0.7 -0.45 -2.91
    PEG Ratio
    		 -0.00 -0.1 -0.01 -0.01
    PS Ratio
    		 n/a 31.56 8.55 n/a
    PB Ratio
    		 7.16 -5.59 -17.45 1.87
    P/FCF Ratio
    		 -1.86 -1.16 -0.52 -5.33
    P/OCF Ratio
    		 -1.86 -1.17 -0.52 -5.36
    OCF/S Ratio
    		 n/a -27.09 -16.46 n/a
    Debt / Equity Ratio
    		 0.10 -0.21 -0.33 0.02
    Quick Ratio
    		 1.28 0.76 0.81 8.75
    Current Ratio
    		 1.28 0.76 0.81 8.75
    Asset Turnover
    		 n/a 0.05 0.34 n/a
    Interest Coverage
    		 -452.35 -253.34 -3.01K -14.29
    Return on Equity
    		 -4.94 8.02 38.76 -0.64
    Return on Assets
    		 -1.16 -2.15 -6.41 -0.57
    Return on Invested Capital
    		 -3.8 6.93 115.76 -0.56
    Dividend Yield
    		 0.02 n/a n/a n/a
    Payout Ratio
    		 -0.03 n/a n/a n/a
    Gross Profit Margin
    		 n/a 1.00 0.99 n/a
    Net Profit Margin
    		 n/a -45.25 -18.99 n/a
    Pretax Profit Margin
    		 n/a -45.25 -18.99 n/a
    Operating Profit Margin
    		 n/a -30.78 -18.98 n/a
    FCF Margin
    		 n/a -27.1 -16.46 n/a
    EBITDA Margin
    		 n/a -44.71 -18.97 n/a

    Add to Watchlist